BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1360799)

  • 1. Protective effects of verapamil on cis-platinum and carboplatinum nephrotoxicity in dehydrated and normohydrated rats.
    Haragsim L; Zima T
    Biochem Int; 1992 Oct; 28(2):273-6. PubMed ID: 1360799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nephrotoxic effects of platinum cytostatics--preventative effects of nifedipine and cimetidine.
    Haragsim L; Zima T; Nĕmecek K
    Sb Lek; 1994; 95(3):173-83. PubMed ID: 8711347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The preventive effect of calcium-channel blockers (nifedipine, verapamil) on the tubular toxicity of radiographic contrast media (Verografin, Hexabrix)].
    Haragsim L; Zima T
    Cas Lek Cesk; 1993 Dec; 132(24):737-42. PubMed ID: 7905791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obstructed versus dilated nonobstructed kidneys in children with congenital ureteropelvic junction narrowing: role of urinary tubular enzymes.
    Taha MA; Shokeir AA; Osman HG; Abd El-Aziz Ael-A; Farahat SE
    J Urol; 2007 Aug; 178(2):640-6. PubMed ID: 17574624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor effects of three platinum complexes, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato)-platinum (II) monohydrate (DWA2114R), cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) (CBDCA) and cis-diamminedichloroplatinum(II) (CDDP), in mice.
    Endo K; Akamatsu K; Matsumoto T; Morikawa K; Koizumi M; Mitsui H; Koizumi K
    Anticancer Res; 1992; 12(1):49-58. PubMed ID: 1567181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relation of enzyme distribution in the kidney and increase pattern of urinary N-acetyl-beta-D-glucosaminidase (NAG) and gamma-glutamyl transpeptidase (gamma-GTP) activities following CDDP administration].
    Takahashi T; Yoshida K; Nakame Y; Saitoh H
    Hinyokika Kiyo; 1987 Oct; 33(10):1569-74. PubMed ID: 2895573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A clinical evaluation of the protective effect of fosfomycin (FOM) against the cis-diamminedichloroplatinum (CDDP)-induced nephrotoxicity].
    Saito M; Masaki T; Kato H; Numasaka K
    Hinyokika Kiyo; 1988 May; 34(5):782-9. PubMed ID: 3051938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of the acute nephrotoxicity from standard dose cisplatin +/- ifosfamide and high-dose chemotherapy with carboplatin and ifosfamide.
    Hartmann JT; Fels LM; Franzke A; Knop S; Renn M; Maess B; Panagiotou P; Lampe H; Kanz L; Stolte H; Bokemeyer C
    Anticancer Res; 2000; 20(5C):3767-73. PubMed ID: 11268452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Urinary NAG and gamma-GTP activities as indicators of CDDP renal toxicity: effect of fosfomycin on CDDP renal toxicity].
    Yoshida K; Takahashi T; Nakame Y; Saitoh H; Horiuchi S; Kaneoya F; Negishi T
    Hinyokika Kiyo; 1986 Sep; 32(9):1237-45. PubMed ID: 2880486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal toxicity of cadmium-metallothionein and enzymuria in rats.
    Suzuki CA; Cherian MG
    J Pharmacol Exp Ther; 1987 Jan; 240(1):314-9. PubMed ID: 2879904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nephrotoxicity of a novel antineoplastic platinum complex, nedaplatin: a comparative study with cisplatin in rats.
    Uehara T; Watanabe H; Itoh F; Inoue S; Koshida H; Nakamura M; Yamate J; Maruyama T
    Arch Toxicol; 2005 Aug; 79(8):451-60. PubMed ID: 15856183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of calcium channel blockers on cyclosporine A (Cs A) induced nephrotoxicity in rats.
    Zima T; Nĕmecek K; Hátle K; Bártová V; Stípek S
    Sb Lek; 1995; 96(1):15-21. PubMed ID: 8711361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Measurement of creatinine clearance and urinary NAG for the evaluation of cis-platinum induced nephrotoxicity].
    Kubota A; Yoshida T; Tsukuda M; Furukawa S; Miyata K; Mochimatsu I; Sawaki S
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2599-605. PubMed ID: 2774590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Demonstration of seasonal changes of circadian rhythms of amikacin chrononephrotoxicity in rats].
    Dorian C; Catroux P; Cambar J
    Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):731-4. PubMed ID: 2889179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of methods for evaluating the nephrotoxicity of cisplatin].
    Suzumori K; Yasui Y; Suzumori K; Yagami Y; Seki T
    Gan To Kagaku Ryoho; 1988 Aug; 15(8):2251-6. PubMed ID: 3044273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interactions of cis-diamminedichloroplatinum with metallothionein and glutathione in rat liver and kidney.
    Suzuki CA; Cherian MG
    Toxicology; 1990 Nov; 64(2):113-27. PubMed ID: 1977210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection against cisplatin-induced nephrotoxicity by Spirulina in rats.
    Mohan IK; Khan M; Shobha JC; Naidu MU; Prayag A; Kuppusamy P; Kutala VK
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):802-8. PubMed ID: 16552571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vancomycin-induced nephrotoxicity in rats: is enzyme elevation a consistent finding in tubular injury?
    Naghibi B; Ghafghazi T; Hajhashemi V; Talebi A
    J Nephrol; 2007; 20(4):482-8. PubMed ID: 17879216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study on urinary gamma-GTP activities as an indicator of cis-diamminedichloride platinum nephrotoxicity].
    Takahashi T; Yoshida K; Nakame Y; Saitoh H
    Hinyokika Kiyo; 1986 Jun; 32(6):789-94. PubMed ID: 2876605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary excretion of beta 2-microglobulin and N-acetyl-beta-D-glucosaminidase in advanced neuroblastoma patients receiving cis-diamminedichloroplatinum(II).
    Ikeda H; Nagashima K; Okumura H; Takahashi A; Matsuyama S; Nagamachi Y
    Eur J Surg Oncol; 1988 Feb; 14(1):17-20. PubMed ID: 3278937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.